AbCellera Biologics Inc. ABCL Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s pre-tax income?
- AbCellera Biologics Inc. (ABCL) reported pre-tax income of -$49.54M in Q1 2026.
- How has AbCellera Biologics Inc.'s pre-tax income changed year-over-year?
- AbCellera Biologics Inc.'s pre-tax income increased by 6.5% year-over-year, from -$52.98M to -$49.54M.
- What is the long-term trend for AbCellera Biologics Inc.'s pre-tax income?
- Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s pre-tax income has grown at a -6.8% compound annual growth rate (CAGR), from $219.15M to -$177.6M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.